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Abstract
Background: Infections with Salmonella cause significant morbidity and mortality worldwide.
Replication of Salmonella typhimurium inside its host cell is a model system for studying the
pathogenesis of intracellular bacterial infections. Genome-scale modeling of bacterial metabolic
networks provides a powerful tool to identify and analyze pathways required for successful
intracellular replication during host-pathogen interaction.
Results:  We have developed and validated a genome-scale metabolic network of Salmonella
typhimurium LT2 (iRR1083). This model accounts for 1,083 genes that encode proteins catalyzing
1,087 unique metabolic and transport reactions in the bacterium. We employed flux balance
analysis and in silico gene essentiality analysis to investigate growth under a wide range of conditions
that mimic in vitro and host cell environments. Gene expression profiling of S. typhimurium isolated
from macrophage cell lines was used to constrain the model to predict metabolic pathways that
are likely to be operational during infection.
Conclusion: Our analysis suggests that there is a robust minimal set of metabolic pathways that
is required for successful replication of Salmonella inside the host cell. This model also serves as
platform for the integration of high-throughput data. Its computational power allows identification
of networked metabolic pathways and generation of hypotheses about metabolism during infection,
which might be used for the rational design of novel antibiotics or vaccine strains.
Background
Salmonellae are Gram-negative bacterial pathogens with a
wide host range. The ability of Salmonella enterica to cause
disease is closely correlated with its ability to survive
inside its host cells, which include epithelial cells and
macrophages [1]. Infection of mice with Salmonella enter-
ica serovar Typhimurium (S. typhimurium) serves as model
for the systemic disease typhoid fever. Salmonella strains
that are deficient for intra-macrophage survival cannot
elicit disease in the mouse model. Many genomic and pro-
teomic datasets exist for Salmonella as a pathogen [2-6].
Most experiments have focused on identifying 'virulence'
factors that might drive the disease process, such as surface
structures or secreted products. Differential expression of
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metabolic gene-products has largely been left unexplored
in terms of their role in pathogenesis. However, it has now
gained more attention that the metabolism of intracellu-
lar bacterial pathogens such as Salmonella  may hold
important clues to understanding their intracellular life-
style as well as to understanding host defense mechanisms
[7,8]. Genome-scale metabolic in silico models that can
integrate and exploit genomic and proteomic data may
provide a first step towards a quantitative analysis of the
metabolism of intracellular bacteria.
Constraint-based reconstruction and analysis (COBRA) of
cellular metabolism has been employed successfully to
develop organism-specific genome-scale in silico models
across all the three major domains of the tree of life [9-
12]. The COBRA approach seeks to differentiate between
those network states that are achievable by the organism
from those that are not, based on a detailed reconstruc-
tion of metabolism and incorporation of physiological
parameters that are consistent with known experimental
information [13]. The solutions this analysis provides are
based on the successive imposition of governing physico-
chemical constraints on genome-scale reconstructions.
COBRA integrates and represents our current knowledge
of network components and interactions and has been
applied to several prokaryotic and eukaryotic organisms,
including Escherichia coli [9], Helicobacter pylori [14], Hae-
mophilus Influenzae [15], Saccharomyces cerevisiae [16] and
Geobacter sulfurreducens [17]. By systematizing and provid-
ing context for transcriptomic, proteomic, and metabo-
lomic data, these models allow for the imposition of
constraints, which together define the possible pheno-
typic behavior allowed by these in silico organisms. The
use of constrained based modeling has significant poten-
tial to identify new antibacterial targets [18]. Modeling
allows simulation of single gene knockouts and, more
importantly, the effect of combinatorial deletions, which
might allow the rational development of combination
drug therapy. The use of such a modeling approach has
been demonstrated for H. influenza [15] and for Mycobac-
terium tuberculosis [8]. As the number of pathogens with
such models grows [19-24,8], one might expect that more
basic principles of bacterial metabolism needed for patho-
genesis can be derived.
Here we describe the reconstruction of a detailed and val-
idated genome-scale metabolic network for S. typhimu-
rium, that reconciles established genomic and high-
throughput phenotyping data and that is augmented by
experimental data to facilitate iterative model building
efforts. Furthermore, we demonstrate how the model can
be used to reconcile existing virulence data and to resolve
gaps in our understanding of pathogen metabolism and
host-cell nutrient environment. We also use gene expres-
sion data obtained for this study in combination with
established microarray and proteomic data in the context
of the model to understand pathogen metabolism in mac-
rophage cell lines.
Results
Characteristics of the Reconstructed Metabolic Network
The 4,857-kilobase (kb) chromosome of Salmonella enter-
ica serovar typhimurium LT2 (S. typhimurium LT2) accounts
for 4,489 coding sequences (CDS/ORFs) including 39
pseudogenes and a 94 kb plasmid encoding 108 ORFs
[25]. The in silico metabolic reconstruction of the bacte-
rium referred to as iRR1083 contains only annotated chro-
mosomal genes. The characteristics of the network are
detailed in Figure 1A and 1B (for details see Additional file
1). It currently accounts for 1,083 genes that encode pro-
teins catalyzing 1,087 unique metabolic and transport
reactions in the bacterium. The reconstruction includes
gene to protein to reaction association relationships,
which distinguish between isozymes, multimeric proteins
and protein complexes [26]. The reconstruction contains
all the biosynthesis pathways to make biomass compo-
nents that are required for growth. A biomass production
reaction was formulated, which is based on the measured
biomass composition of the bacterium and which details
the required metabolites and their relative amounts.
The reconstruction accounts for central metabolism, car-
bohydrate utilization, amino acid biosynthesis and degra-
dation, nucleotide biosynthesis and salvage, and cofactor
biosynthesis (see Additional file 1). Also included were
anaerobic and aerobic electron transport chain reactions,
transport reactions for various minerals and small mole-
cules, and biosynthesis reactions for cell wall constituents
and precursors, such as phospholipids and peptidoglycan.
Lipid biosynthesis in bacteria involves (i) fatty acid bio-
synthesis, (ii) attachment of the complete fatty acids to sn-
glycerol-3-phosphate, and (iii) addition and modification
of head groups to yield the major cellular phospholipids.
Fatty acids are important constituents of lipid A and the
cell wall of bacteria. In contrast to published models of
other microbes that used compositional data of E. coli, we
have directly measured amino acid, fatty acid and lipid
profiles for Salmonella  LT2 (see Additional file 2) and
incorporated them into our reconstruction in iRR1083.
Since fatty acid synthesis has also become a recent target
of new antimicrobial drugs, it is critical to represent fatty
acids and lipids accurately for different pathogens.
In addition to accounting for these major aspects of cell
metabolism and biosynthesis, the reconstruction also
includes reactions required for drug efflux, proton pumps,
and inhibitory effects of antibiotics on bacterial metabo-
lism. We have included the AcrAB-TolC multi-component
drug efflux pump which has been characterized in S. typh-BMC Systems Biology 2009, 3:38 http://www.biomedcentral.com/1752-0509/3/38
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imurium. This efflux pump has been shown to be involved
in the resistance to β-lactams (ampicillin and penicillin
G), fluoroquinolone (ciprofloxacin and fluoroqui-
nolone), cefotaxime, and chloramphenicol [27-29]. An
increase in the expression levels of this pump has been
recognized as a significant determinant of antibiotic
resistance in bacterial pathogens. The inclusion of this
efflux pump allows modeling of the reaction of Salmonella
to antibiotics, by varying efflux pump activity and/or lim-
iting metabolic flux through the respective pathways. For
example, β-lactam antibiotics result in incomplete pepti-
doglycan synthesis (D-Ala-D-Ala addition), which can be
modeled by restricting flux through peptidoglycan synthe-
sis. Similarly, dihydropteroate synthase inhibition by sul-
fonamides and dihydrofolate reductase inhibition by
trimethoprim can be simulated by constraining fluxes
through their corresponding reactions.
Another unique aspect of our reconstruction are the reac-
tions involved in free radical quenching that are generally
used by Salmonella to counteract the host cell response to
infection [30,31]. In addition to the classically known
mechanisms mediated by superoxide dismutases, cata-
lases and the enzymes that make and recycle glutathione
and thioredoxin, our reconstruction includes mechanisms
for reactive nitrogen species (RNS) and reactive oxygen
species (ROS) resistance and removal. Some of those
include: a soluble flavohemoglobin (Hmp) with a NO
dioxygenase activity that is induced solely by RNS; and an
alkyl hydroperoxide reductase (AhpC) belonging to the
peroxiredoxin family that is involved in dissipating both
ROS and RNS [31-34]. The inclusion of reactions for ROS
(superoxide, peroxide) and RNS (nitrate, nitrite, nitric
oxide, and nitrous oxide) species make this model a suit-
able platform to analyze their role in infection and patho-
genesis.
Growth predictions
Flux balance analysis (FBA) was used to predict growth
rates on six different carbon sources (glucose, fructose,
arabinose, xylose, ribose and glycerol) using their meas-
ured substrate uptake rates. These in silico predicted
growth rates were then compared to experimental results
of aerobic batch cultivation of S. typhimurium LT2 in M9
minimal media. The calculated maximum specific growth
rate (hr-1) of Salmonella for a given carbon source uptake
rate was close to the experimentally determined values for
S. typhimurium under similar conditions (Figure 1C).
Quantitative differences between calculated and observed
growth rates could be attributed to differences in ATP
maintenance parameters (values for E. coli were used in
the simulations [9]) or secretion of by-products, which
were not predicted in any of the simulations since carbon
sources were assumed to be the limiting nutrient.
Characteristics of metabolic network iRR1083 for Salmonella  typhimurium Figure 1
Characteristics of metabolic network iRR1083 for 
Salmonella typhimurium. (A) Statistics of the S. typhimu-
rium genome and in silico reconstruction iRR1083. The in sil-
ico representation includes Gene-Protein-Reaction 
relationships including isozymes, multimeric protein com-
plexes, and multi-reaction catalyzing enzymes as described in 
the text. (B) Functional classification of genes included in the 
model. (C) Comparison of observed growth rates (experi-
mental) with growth rates predicted by model iRR1083 pro-
viding different carbon sources under aerobic culture 
conditions. Experimental growth rates were calculated using 
the Monod growth equation based on O.D values and a bio-
mass calibration curve as described in Materials and Meth-
ods. For predictions, experimental specific substrate uptake 
rates were calculated from HPLC profiles obtained at differ-
ent time points in the growth curve.
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S. typhimurium is a mixed acid fermenter that metabolizes
glucose via the Embden-Meyerhoff-Parnas pathway [35].
Many of the predicted non-zero fluxes (as calculated using
FBA) corresponded to genes whose mRNA transcript
expression levels were measurable during growth of Sal-
monella (see Additional file 8) on glucose minimal media.
Most of the transcripts detected in our study concur with
previous reports in literature. During growth on glucose
the iRR1083 model predicts that oxaloacetate can be pro-
duced by phosphoenolpyruvate carboxylase (PepC),
which is known to be the only enzyme serving the ana-
plerotic role of replenishing oxaloacetate that is with-
drawn for amino acid biosynthesis. In agreement with our
flux calculations, our experimental results also indicate a
high abundance of the PepC mRNA. The data also indi-
cate that glucose is converted to biomass and some part of
the carbon is diverted into stoichiometric formation of
formate, acetate, ethanol and succinate under anaerobic
conditions [35].
Growth of S. typhimurium on 3 pentoses (D-arabinose, D-
ribose and D-xylose) was also tested experimentally.
Growth was only observed on D-xylose and D-ribose,
which is consistent with literature and model predictions
[36]. Xylose is catabolized, as most other aldopentoses, by
transport into the cell, isomerization and phosphoryla-
tion of ketopentose (xylulose). The phosphorylated deriv-
ative is then converted to xylulose-5-phosphate by an
epimerase and channeled into the pentose phosphate
pathway. D-ribose is transported into the cell, concomi-
tant with the disruption of a high-energy phosphate bond
and enters the pentose phosphate pathway following
epimerization. These results highlight the utility of using
modeling to predict growth on substrates a priori to exper-
imentation and can help understand the different path-
ways that are operational during growth on specific
carbon and nitrogen sources.
Qualitative Growth Phenotypes
FBA was also used to predict which of the 163 carbon con-
taining compounds and 98 nitrogen-containing com-
pounds, with transport reactions (excluding antibiotics)
that are included in the model, could be used for growth
as sole carbon or nitrogen sources. The in silico predictions
were then compared to (1) existing high-throughput phe-
notyping data from Biolog's Phenotyping MicroArray™
technology (Biolog Hayward, Inc., CA; data was available
from the company website) and (2) reports from experi-
mental literature [37]; (Table 1, see Additional file 4 for
complete details).
The model predicted that 113 out of 163 potential carbon
sources could support growth as the sole carbon source,
and 50 out of 98 potential nitrogen sources could support
growth as the sole nitrogen source. Comparisons with
experimental data could be made for 125 of the potential
carbon sources and for 74 of the potential nitrogen
sources. Overall, the model predicted carbon and nitrogen
sources with 82% accuracy for carbon sources and 81%
accuracy for nitrogen sources. The relationship between
model predictions and experimental growth phenotypes
is statistically significant (chi-squared test statistic yields p
< 0.0001 for both carbon and nitrogen sources). Most of
the inaccurately predicted carbon sources are compounds
that can also serve as sole nitrogen sources experimentally
(13 of 21). This suggests that regulation or enzyme kinetic
limitations likely prevent these compounds from being
used by S. typhimurium LT2 as sole carbon sources.
S. typhimurium and E. coli are closely related microorgan-
isms. Comparison of their physiological data and meta-
bolic network structures suggest differences in carbon and
nitrogen source utilization. For example, E. coli can utilize
D-alanine, L-asparagine, L-aspartate, L-glutamine, and D-
lactate as sole carbon sources experimentally, while S.
typhimurium can not, even though S. typhimurium has the
necessary enzymes and transporters. These phenotypic
differences are likely to be caused by differences in how
the organisms control metabolism through regulation
and kinetics rather than by differences in metabolic net-
work structure. The same explanation can be made for car-
bon sources that only S. typhimurium can use even though
both organisms can catalyze the required reactions (1,2-
propanediol, citrate, galactitol, L-glutamate, L-proline,
and L-tartarate).S. typhimurium is also predicted to be able
to utilize additional carbon sources due to the presence of
unique transporters and/or enzymes (4-hydroxyphenylac-
etate, deoxyribose, ethanolamine, myo-inositol, L-lyxose,
D-tartrate, D-glycerate, 2-phosphate-D-glycerate, 3-Phos-
pho-D-glycerate, L-cysteine, isocitrate, phosphoenolpyru-
vate and tricarballylate).
Table 1: In silico predictions and experimental data.
Model Predictions Experimental Growth Experimental No Growth No Data Total
Growth (Carbon) 75 21 17 113
No Growth (Carbon) 12 8 2 1 5 0
Growth (Nitrogen) 37 5 8 50
No Growth (Nitrogen) 92 3 1 6 4 8
Comparisons between model predictions (rows) and experimental data (columns) taken from Biolog and published literatureBMC Systems Biology 2009, 3:38 http://www.biomedcentral.com/1752-0509/3/38
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Analysis of gene deletions, essentiality and lethal genes
The impact of single gene deletions on growth of S. typh-
imurium LT2 was analyzed by simulating its growth on
rich medium in the absence of the reactions catalyzed by
the corresponding gene. The results were compared for
consistency with a compiled list of 255 essential genes
from a large-scale gene essentiality screen. Of the 255
essential genes, only 74 were included in iRR1083 and
could be compared with experimental results. The total
accuracy of essentiality predictions was around 40% (30
out of 74). The accuracy of predicting in vivo essential
genes for growth in rich media is within the range
reported for models of Pseudomonas aeroginosa (40%)
[21], H. pylori (57%)[14], and Bacillus subtilis (69%)[11].
Discrepancies between model predictions and experimen-
tal results can be used to better identify what metabolites
are present in the rich media and lead to model improve-
ments. For example, inclusion of charged tRNAs rather
than free amino acids into the biomass reaction would
lead to the correct prediction of amino acid tRNA syn-
thetases as essential genes.
To further explore the metabolic differences between E.
coli and S. typhimurium we compared gene essentiality pre-
dictions for in silico aerobic growth in glucose minimal
media using the most recent E. coli metabolic reconstruc-
tion, iAF1261 [9] and iRR1083 (see Additional file 5). The
number of predicted essential genes was fairly similar for
the two organisms, with E. coli having 237 (out of 1261)
essential metabolic genes and S. typhimurium having 200
(out of 1083) essential metabolic genes. The two models
have 900 overlapping orthologs, meaning there are 183
genes included in iRR1083 which do not have an ortholog
included in iAF1261 (142 of these do not have orthologs
in E. coli and another 41 of the E. coli orthologs were not
included in iAF1261).
For 667 of the 900 overlapping orthologs both models
predict the genes to be non-essential for in silico growth in
a glucose minimal medium under aerobic conditions. The
models also agree on 136 of the 900 orthologs being
essential. Comparing the predictions to experimental E.
coli knock-out mutant phenotypes (in rich and glucose
minimal media [38,39], the conserved non-essential pre-
dictions and essential predictions were both 89% accurate
(595/667 and 122/136, respectively).
The discrepancies between essentiality predictions made
by the two models can be useful in identifying model dif-
ferences (biomass formulation and reaction reversibility)
and metabolic network differences (isozymes and unique
reactions) for the two microorganisms. In 45 of the 900
overlapping orthologs, the E. coli model predicted genes
as essential and the S. typhimurium model predicted
those genes as non-essential; in 52 cases the S. typhimu-
rium model predicted genes as essential and the E. coli
model predicted those as non-essential. Most of these dis-
crepancies (~74%) can be attributed to differences in the
biomass formulations that were used for the two models.
The  S. typhimurium model either has additional com-
pounds (such as a complete lipopolysaccharide, glycogen,
and spermidine) that cannot be produced in a gene's
absence (contributing to 35 out of 52 discrepancies), or
the E. coli model has additional compounds (such as thi-
amine diphosphate, pyridoxine 5'-phosphate, ubiqui-
none, and protoheme) that cannot be produced in a
gene's absence (contributing to 37 out of 45 discrepan-
cies).
Reaction reversibility differences are also responsible for
some of the discrepancies. In the S. typhimurium model
threonine aldolase is reversible so that threonine can be
produced from glycine and acetaldehyde; however, this
reaction was changed to irreversible in the updated E. coli
model, iAF1261. As a result the biosynthetic genes for
threonine production encoding homoserine kinase (thrB)
and threonine synthase (thrC) are predicted to be essential
by the E. coli model. In contrast, the S. typhimurium model
predicts that in their absence threonine can be synthesized
from glycine and acetaldehyde. Since both thrB and thrC
are essential for E. coli growth in minimal media condi-
tions [38] it is likely that threonine aldolase does not pro-
duce threonine. Glycine hydroxymethyltransferase also
differs in its reversibility between the two models, where
it is reversible in iAF1261 and irreversible in iRR1083. The
reversible reaction provides another pathway in the E. coli
model for serine production in the absence of phospho-
serine phosphatase (serA) or 3-phosphoglycerate dehy-
drogenase (serB), and explains why these two enzymes are
predicted to be essential for S. typhimurium growth and
non-essential for E. coli growth. Since both serA and serB
are essential experimentally in E. coli [38], it is likely that
neither organism uses glycine hydroxymethyltransferase
for serine production, which is consistent with the S. typh-
imurium model predictions.
Gene essentiality discrepanices caused by metabolic net-
work differences, such as additional reactions and/or iso-
zymes, provide interesting insights. For example, S.
typhimurium has genes encoding for two separate 3-isopro-
pylmalate dehydratases (encoded by STM0110-STM0111
and STM0329-STM0330) while E. coli only has genes for
one (encoded by b0071-b0072). As a result, when
STM0110 or STM0111 are deleted the iRR1083 model
predicts that STM0329 and STM0330 can be used instead
to produce leucine, which is not possible in E. coli since it
lacks the second isozyme. S. typhimurium also carries out
reactions that E. coli can not. For example, an NADPH
dependent sulfite reductase (unique to S. typhimurium) is
predicted to be used for hydrogen sulfide productionBMC Systems Biology 2009, 3:38 http://www.biomedcentral.com/1752-0509/3/38
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(needed for cysteine biosynthesis) when the NADH
dependent sulfite reductase (present in both organisms) is
absent.
There are also cases where E. coli has additional isozymes
or metabolic reactions, that explain why genes are pre-
dicted to be non-essential in E. coli but essential in S. typh-
imurium. For example, there are multiple carbonic
anhydrases and dihydrofolate reductases in E. coli while S.
typhimurium has only one copy of each of these essential
enzymes. E. coli also contains a gene encoding ribose 1,5-
bisphosphokinase, for which there is no ortholog in S.
typhimurium. This E. coli specific enzyme is predicted by
the iAF1261 model to compensate for ribose-phosphate
pyrophosphokinase in 5-phospho-alpha-D-ribose 1-
diphosphate production, which is needed for histidine
and nucleotide biosynthesis in the absence of ribose-
phosphate pyrophosphokinase [40]. As shown here, com-
parisons between gene essentiality predictions can be use-
ful in identifying model discrepancies which can lead to
updated and improved models, as well as identification of
unique metabolic features, which allow for discovery of
possible phenotypic differences between two organisms.
Metabolic gene essentiality for virulence
The identification of genes essential for survival is also
important for understanding the minimal requirements
for pathogen survival in the host cell and to subsequently
identify targets for new antibiotics. A list of genes pre-
dicted to be essential for in silico growth of iRR1083 was
compiled and compared with a set of in vivo essential and
non-essential genes from the literature (Figure 2A and
2B). Genes essential in vivo are those that are reported to
be required for growth. Hence, Salmonella mutants defec-
tive in these essential genes are avirulent in macrophage
or animal models, while mutants defective in non-essen-
tial genes are still virulent and can grow. An attenuated
mutant strain is capable of growth in vivo at a lower rate
than the wildtype. This is consistent with the physiologi-
cal definition of virulent, avirulent and attenuated strains
in literature [41]. Since the availability of nutrients in the
macrophage or animal host has not been completely
delineated we have used an approximate representation
based on that indirectly inferred from existing literature
(see Additional file 6). Model predicted growth rates are
highly sensitive to nutrient uptake rates which are
unknown in the host celll. The model was not used to dis-
tinguish between attenuated and virulent phenotypes as
this would require detailed nutrient uptake rate measure-
ments. Instead mutants were only predicted to be virulent
(maximum growth rate is greater than zero) or avirulent
(maximum growth rate is zero).
The iRR1083 reconstruction as described earlier only con-
tains metabolic genes, so there are additional non-meta-
Gene essentiality Comparison (A) in silico predictions of  lethal genes were compared with an experimentally gener- ated screen (in vitro in LB media) that defines an essential  metabolic genes set for S. typhimurium Figure 2
Gene essentiality Comparison (A) in silico predic-
tions of lethal genes were compared with an experi-
mentally generated screen (in vitro in LB media) that 
defines an essential metabolic genes set for S. typh-
imurium. ++,-,† and indicates virulent, avirulent, and attenu-
ated mutants. * The model was not used to distinguish 
between attenuated and virulent phenotypes as this would 
require detailed nutrient uptake rate measurements. Instead 
mutants were only predicted to be virulent (maximum 
growth rate is greater than zero) or avirulent (maximum 
growth rate is zero). (B) Comparison of in-silico predicted 
viability and virulence of metabolic gene mutants that have 
been implicated in vivo for virulence. (C) In silico prediction 
statistics for viability and virulence of the in vivo tested 
mutants (2A) before and after accounting for auxotrophic 
requirements and nutrient availability in the host.
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bolic essential genes in vivo that were not included in our
virulence prediction study. The in silico virulence predic-
tions matched in vivo virulence characterization for 92%
(22/24) of the in vivo virulent mutants and 56% (9/16) of
the in vivo avirulent mutants. Most attenuated strains were
also correctly predicted by the model to still be able to
grow (13/15). Again a statistically significant relationship
between model predictions and experimental observa-
tions was found (χ2 = 10.9 and p = 0.001). The model pre-
dicted incorrectly that mutants defective in pmrF and udg
were avirulent [42,43]. Both of these genes are involved in
the biosynthesis of the aminoarabinose component of
lipopolysaccharide (which is attached to Lipid A). How-
ever, this aminoarabinose component of the LPS is not
always present. If alternate LPS structures were also
included in the model then the model would accurately
predict the virulence of pmrF and udg mutant strains. This
would increase the final virulence prediction accuracy to
100%. The consistencies and discrepancies between in sil-
ico and in vivo mutant phenotypes deserve further discus-
sion and may generate potential hypotheses that can
subsequently be tested.
Some genes that are involved in major central metabolic
pathways and are non-essential for intracellular survival
(i.e. mutants defective in these genes are virulent) are dis-
cussed below. AceA encodes isocitrate lyase, which cata-
lyzes the first step in the glyoxylate shunt, an anaplerotic
carbon assimilatory pathway that synthesizes C4 dicarbo-
xylates from C2 compounds like acetate or short chain
fatty acids. AceA is required only for chronic Salmonella
infections and not for acute infections [44]. This enzyme
is generally used when substrates such as glucose or pyru-
vate are absent and acetate or fatty acids are present. AckA
and Pta are two enzymes in salmonella that lead to acetyl
phosphate formation and the double deletion strain is vir-
ulent. Acetyl-phosphate is thought to activate expression
of invasion genes, which can also be activated via a sen-
sory kinase BarA. However, virulence is decreased only
when Pta, AckA, and BarA are deleted [45].
Phagocytic cells are able to generate superoxide, hydrogen
peroxide and other reactive oxygen species (ROS) and
pathogens possess multiple defenses to such oxidative
stresses. The model also accurately predicted that catalase
(katE and katG) mutants [46] and super oxide dismutase
mutants (sodA and sodCII) [47,48] are virulent. Mutants
lacking a third superoxide dismutase (sodCI) are attenu-
ated and the model incorrectly predicts that a sodCI
mutant would be virulent; however, if the host-cell envi-
ronment included superoxide and none of the other
superoxide dismutases were expressed or active (sodA,
sodB, and sodCII) then the bacterium would have no way
of dissipating superoxide and the model would predict an
avirulent phenotype.
One of the incorrect predictions for the experimentally
determined avirulent strains was for the nagA  mutant.
NagA is a N-acetylglucosamine-6-phosphate deacetylase,
and it's substrate acts as an inducer of the nag operon,
which relieves repression by NagC. It has been proposed
that nagA mutants indirectly lead to reduction in amino-
sugar biosynthesis, which is needed in membrane struc-
tures [49]. The model's inability to identify this mutant
correctly as being avirulent could be due to the absence of
any regulatory mechanisms not accounted for in the
model. Inclusion of simple regulatory rules as has been
done for the E. coli model, would allow us to address the
role of regulation of metabolism during Salmonella-host
interaction.
Of the experimentally determined attenuated mutants,
the model predicted that mutants defective in aromatic
amino acid biosynthesis are avirulent (aroABCD). Aro Sal-
monella strains have been used as oral vaccines [50]. The
attenuation of this strain, which is accomplished by inter-
rupting pathways for biosynthesis of aromatic amino
acids, is consistent with our in silico analysis. Strains of S.
typhimurium with complete non-reverting blocks in aro-
matic biosynthesis are avirulent [51] as predicted by our
model.
A large portion of the experimentally determined aviru-
lent mutants which were incorrectly predicted by the
model to be virulent are associated with nucleotide bio-
synthesis:  guaAB,  purAB, and thyA  (Figure 3). These
mutants were all predicted to be virulent due to the inclu-
sion of thymidine, guanosine, adenosine, and deoxyade-
nosine into simulations of the host-cell environment. If
these metabolites are not available, then the model cor-
rectly predicts that these strains are avirulent. Other
mutant strains defective in purine biosynthesis genes
(purC, purE, purF, and purG) are attenuated rather than
avirulent [51]. The experimental results indicate that
intermediates in the purine biosynthesis pathway (eg.
hypoxanthine or inosine) are available in the host-cell
environment and that guanosine and adenosine are likely
produced from these pathway intermediates rather than
provided by the host (Figure 3). Better accounting for
nutrient availability in vivo is then able to resolve 62.5%
of the mutants that were incorrectly predicted in silico to
be virulent. This approach can thus also serve as an indi-
rect probe of the host cell intracellular environment in
which the pathogen finds itself.
Pseudogenes and their role in infection among serovars of 
Salmonella
Sixty-five genes that are included in iRR1083, and thus
present in Salmonella serovar typhimurium, are missing or
are pseudogenes in other Salmonella serovars (see Addi-
tional file 7) [52]. This implies that these genes could beBMC Systems Biology 2009, 3:38 http://www.biomedcentral.com/1752-0509/3/38
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dispensable for virulence. Based on the in silico analyses of
the effect of single gene deletions on growth of S. typhimu-
rium in both rich media and host-cell environments, all
65 genes are predicted to be dispensable. Only one gene
out of these 65, panD, was predicted to be required for
growth in minimal media. PanD is required for panthoth-
enate synthesis, an intermediate in the biosynthesis of
CoA. In E. coli this enzyme is not required for growth in
LB but is required for growth in minimal media [38,39].
Presumably then, serovars lacking panD  would require
panthothenate from its host. Compounds that affect pan-
tothenate transport could potentially be used as antibiot-
ics.
Salmonella Metabolism in infection
The transcriptional status of in vivo derived bacteria may
correlate with mechanisms of pathogen survival and pro-
liferation within host cells. Such genome-scale expression
profiles are indicative of the host cell environment as well
as the pathogen's adaptation to the intracellular niche.
Based on a complete transcriptional profile of intracellu-
lar Salmonella following short-term (4 h–12 h) infection
of macrophage cell lines, only 21% of the total genes in
the genome are differentially expressed (Figure 4A). Fur-
ther, only about 6% of these are characterized metabolic
genes of known function. Since it is known that some
metabolic genes are essential for intracellular replication
[52,53] and that Salmonella's niche in the host has limited
nutrient potential, the pathogen appears to have effi-
ciently adapted to minimize its metabolic capacity in
order to survive and grow in the phagosome.
We sought to identify genes (Figure 4B) and select path-
ways that may be crucial for Salmonella's infection of and
growth inside macrophage cell lines by quantitatively
monitoring the expression of 100 selected metabolic
genes (see Additional file 8) that are involved in different
key pathways. Since only a small percentage of metabolic
genes were hypothesized to change mRNA abundance lev-
els during infection, we use the Genomelab Expression
profiler (GEXP) for estimating gene expression quantita-
tively. This technique combines RT-PCR and capillary gel
electrophoresis in a high-throughput format to obtain
accurate, consistent mRNA abundance levels for expressed
transcripts of chosen genes rapidly. Consistent with meta-
bolic gene essentiality hypothesis suggested in literature,
only 24% of the genes chosen in this study were up-regu-
lated 24 hrs post infection. Our data indicates that isoci-
trate lyase (aceA), and fatty acid degradation genes fadA,
fadD/fadE are not expressed. Although these genes have
been implicated for virulence in chronic Salmonella infec-
tion, they are known to be unchanged during short-term
infection experiments [2]. Our results suggest the presence
of glucose or pyruvate and not acetate or short chain fatty
acids in vivo during the early stages of infection as sug-
gested in literature [44]. This also explains why genes from
the oxidative branch of the TCA cycle (gltA, sdh) are over
expressed.
The simultaneous up regulation of succinate dehydroge-
nase and electron transport chain genes cyoE and cyoA is
suggestive of an aerobic environment in vivo, at least dur-
ing the early stages of infection [54]. Increased levels of
F1F0 ATP synthase subunits measured within our data set
also support this. ATP synthase is primarily responsible
Attenuated and avirulent mutants defective in purine biosyn- thesis Figure 3
Attenuated and avirulent mutants defective in purine 
biosynthesis. Attenuated mutants are framed in grey and 
avirulent mutants are framed in black For unframed genes we 
could not find information about their corresponding mutant 
phenotypes in the literature. As shown at the bottom, the 
host cell is assumed to provide purine nucleosides and bases 
that can be converted into the required nucleotides via sal-
vage pathways. However, in silico analysis of mutant pheno-
types suggests that not all nucleosides (corresponding to the 
grey boxes: adenosine, deoxyadenosine and guanosine) are 
provided in sufficient quantities to allow for auxotrophic 
growth.
PRPP
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guaA
XMP
GMP
guaC
Avirulent
Attenuated
Adenosine
Deoxyadenosine
Hypoxanthine
Inosine
GuanosineBMC Systems Biology 2009, 3:38 http://www.biomedcentral.com/1752-0509/3/38
Page 9 of 16
(page number not for citation purposes)
for the oxidative phosphorylation of ADP to ATP. It also
plays a role in maintaining the proton gradient to main-
tain intracellular pH and drive efflux pumps. The high lev-
els of mRNA transcripts for succinate dehydrogenase and
protoheme farnesyl transferase genes also suggest heme
biosynthesis occurs in S. typhimurium during infection.
These are in concurrence with other existing data sets [5].
Genes belonging to the histidine biosynthesis cluster
(hisC, hisD, hisG) were up regulated and those involved in
aromatic amino acid synthesis pathways (aroA,  pheA)
were down regulated. These findings are consistent with
the literature [2]. Genes involved in nucleotide (purF) and
NAD biosynthesis (nadE) were down regulated or not
detected. The down regulated genes also included those
involved in glycolysis and carbon metabolite repression,
certain amino acid decarboxylases and some transporter
genes including drug efflux genes. These results suggest
that Salmonella acquires a significant amount of essential
nutrients directly from the host cell, thus shutting down
several biosynthetic pathways when inside the host. The
genes that cannot be detected include some genes
involved in glycolysis/gluconeogenesis (glk, pps) and ana-
plerotic reactions (ppc). Other genes are detectable, but do
not change in expression level over the course of infection,
including those in the pentose phosphate pathway (zwf),
Entner Duoduroff pathway (edd) and glutathione cycle
(ggt, gst). Fatty acid biosynthesis and degradation genes
are also not detected during the monitored early stages of
infection.
Metabolic capacity of S. typhimurium in the host cell
In silico prediction of metabolic pathways utilized during
infection allows us to identify redundant metabolism that
the pathogen could exploit in order to survive and repli-
cate. During conditions of infection it is reasonable to
assume that Salmonella cells are under an energy limita-
tion. Hence, ATP generated is fully coupled to biosynthe-
sis and growth [55]. Given the possible nutrients provided
in the host-cell environment, we used flux variability anal-
ysis (FVA) to identify which reactions can be utilized [56]
and found that 417 reactions span a large range of flux val-
ues (Figure 5A) when biomass production is optimal.
These 417 reactions (see Additional file 3) encompass all
the possible reactions (reactome) that could be used by
Salmonella during infection. When the biomass produc-
tion is allowed to be suboptimal (ie. values less than the
maximum biomass production), an additional 319 reac-
tions (736 in total) could be used by Salmonella in the
host cell environment (see Additional file 3). The con-
straining conditions of the simulation (listed as media
composition in Additional file 6), were derived by litera-
ture mining to identify a media composition that could
closely mimic nutrient availability for S. typhimurium in
the host cell. We also used FVA to identify blocked reac-
tions and thus pathways that will never be used by the
pathogen under the described conditions in vivo during
infection. These reactions are typically those catalyzed by
proteins that cannot be detected in the proteome or those
genes that are down regulated under similar conditions.
Our model simulation results of these blocked reactions
(see Additional file 3) along with our gene expression data
identify correctly fatty acid degradation metabolic genes
(complete fad operon) to be non-operational during the
above conditions. Thus, there is some correlation between
blocked reactions found by FVA and unexpressed genes
during infection.
S. typhimurium metabolism during infection Figure 4
S. typhimurium metabolism during infection. (A) Func-
tional Classification of metabolic gene subsets analyzed for 
expression in macrophage 24 hr post infection. (B) Subset of 
metabolic genes up-regulated in S. typhimurum 24 hr after 
infection of macrophage cell lines (RAW 246.7). Genes impli-
cated in energy metabolism, heme and aromatic amino acid 
are most up-regulated.
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We compiled the list of all proteins that comprise the in
silico  reactome and compared that to previously deter-
mined proteome of S. typhimurium extracted from macro-
phage cells after infection (Figure 5B). Of the 315 proteins
identified with a high level of confidence in S. typhimu-
rium [5,57], 129 have an annotated metabolic function
(metabolic proteome) and in our model iRR1083. Eighty
of these proteins were associated with reactions present in
the reactome calculated by FVA analysis during optimal
growth, while only 34 were identified in the host-cell reac-
tome when growth was sub-optimal. In another experi-
ment, where the proteome of S. typhimurium was probed
under different in vitro environmental conditions, a total
of 507 proteins were identified [56], of which 127 were
accounted for in our metabolic reconstruction. Out of
these 127 proteins, 83 and 22 were associated with the
optimal and suboptimal host cell reactome, respectively,
as calculated using FVA. Most of the proteins that were
found in both proteomic data sets and associated with
blocked reactions, as calculated by FVA, were tRNA syn-
thetases (7 out of 15 [5] and 13 out of 22 [56]). Incorpo-
rating charged tRNAS instead of free amino acids in the
biomass reaction would change the tRNA synthetase reac-
tions from blocked to part of the optimal reactome and
would result in higher agreement between the optimal
reactome and identified proteins.
Using a similar strategy we compared micro-array gene
expression data obtained from S. typhimurium extracted
from macrophage cells [2]. Of the 919 genes that were dif-
ferentially expressed, 250 genes had a metabolic function,
thus comprising the metabolic transcriptome. When we
compared those with the gene set represented by our FVA
analysis reactome, we identified 80% of the genes in the
metabolic transcriptome were associated with reactions in
the reactome. Of the remaining 49 that were not present
in our in silico reactome, 65% of the genes were down-reg-
ulated and formed a subset of the blocked reactions from
our FVA analysis (Figure 5B). Although the accuracy of
prediction is very good, it could be increased by improv-
ing our knowledge of existing nutrients in the macro-
phage or incorporating regulation into the model. By
identifying preferred metabolic pathways we can better
understand how the pathogen responds to its microenvi-
ronment during invasion and infection.
Discussion
This study describes a genome-scale metabolic model,
iRR1083, of the Gram-negative intracellular pathogen S.
typhimurium. The model has been reconstructed by inte-
gration of existing genomic, proteomic, and phenotypic
experimental data. Comparison between model predic-
Metabolic capacity of S. typhimurium in the host cell or in vivo Figure 5
Metabolic capacity of S. typhimurium in the host cell 
or in vivo. (A) In silico flux range for operational metabolic 
reactions in a simulated host environment using flux variabil-
ity analysis. The plot shows the flux span normalized to the 
maximum cytochrome b556 production flux. The red area 
indicates the flux span during optimal growth of salmonella, 
while the yellow area represents the flux span during subop-
timal growth. During sub-optimal growth, a higher internal 
flexibility is observed as compared to that during optimal 
growth. 417 reactions are predicted to be operational during 
optimal growth and an additional 319 are operational during 
suboptimal of salmonella inside the host cell. (B) Comparison 
of in silico prediction of the reactome (red) to the established 
metabolic proteome (light blue) [5] and transcriptome 
(green) [2] of S. typhimurium extracted from macrophage 
post infection and under different in vitro environmental 
conditions (orange) [56]; 88% of the metabolic proteome, 
80% of the metabolic transcriptome and 83% of the pro-
teome established as a result of 3 different environmental 
responses in vitro are a subset of the in silico predicted reac-
tome. Several genes down regulated in the metabolic tran-
scriptome are associated with blocked reactions (i.e. inactive 
reaction in host cell environment) and correlate with those 
predicted in silico using FVA.
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tions and experimental data demonstrated an accuracy of
more than 80% for growth and virulence phenotypes. The
model allowed us to use flux balance analysis to analyze
growth and virulence genes given the environment the
intracellular pathogen encounters. Further, gene expres-
sion experiments and computational analysis allowed us
to identify metabolic enzymes and pathways that are
potentially active during infection. Model-development is
an iterative process that moves from a genome annotation
and biochemistry of the organism to the development of
a genome-scale metabolic network that can be used as a
fully functional in silico organism to compute physiologi-
cal phenotypes. Our model iRR1083 serves also as a
framework to integrate further gene expression and pro-
teomic data and explain the expression level of specific
gene products during infection.
Computing cellular functions from reconstructed net-
works allowed us to understand the relationship between
environmental factors (nutrient availability) and genetic
factors (mutations or deletions) and their integrated func-
tion to orchestrate cell phenotypes (virulence or attenua-
tion). Knowledge of the functional status of metabolic
genes under defined constraints allows us to interpret the
role of critical nodes in a cellular metabolic network. The
function of redundant pathways under internally per-
turbed conditions, such as in the host cell during infec-
tion, provides important insights into metabolic network
structure. Although this internal robustness has been
experimentally demonstrated, building a complete cata-
log of genes essential for growth under a myriad of condi-
tions for any organism is time-consuming and laborious.
A computational approach that predicts gene essentiality
with high accuracy is thus of great value. Model predic-
tions of virulence for different mutants improved from
80% to 91% upon altering host-cell environment compo-
nents (by adding glutamine, and removing thymidine,
guanosine, adenosine, and deoxyadenosine) and this
shows how the model can be used as a tool for providing
insights into the role of metabolism in infection and
pathogenesis. To date, constraint-based models cannot
predict effects of toxic intermediates and methods are
needed that allow for prediction of concentrations within
constraint-based models.
A biomass reaction (representing the conversion of bio-
mass components into one gram dry weight of biomass)
is needed to accurately predict the effects of gene deletions
on growth and viability. Although predictions have been
made in the past with approximations of the biomass
function to that of E. coli, there are some major differences
in fatty acid and amino acid composition that require
experimental measurements to determine the drain of dif-
ferent metabolites and the cost of their production on the
function of the organism. Our study has addressed this
issue by directly determining the components of Salmo-
nella biomass, thus increasing the validity and predictive
accuracy of model iRR1083.
S. typhimurium is a pathogen that is the leading cause of
human gastroenteritis and is used as a mouse model for
human typhoid fever. Although more than 2000 serovars
exist, the LT2 strain, whose genome sequence has been
used here for building model iRR1083, is one of the prin-
cipal strains for cellular and molecular biology of Salmo-
nella. Attenuated mutants have been used not only as live
oral vaccines against Salmonella  infection but also to
express antigens from other pathogens and to deliver pro-
teins to solid tumors. One reason for attenuation or avir-
ulence is the deletion or functional silencing of a genetic
element in the bacterium resulting in the impairment of
the intracellular survival capacity of S. typhimurium. Our in
silico analysis shows the ability to predict such effects with
good accuracy. At this point the host cell metabolic envi-
ronment has been inferred indirectly from gene-expres-
sion data. Improved accuracy in directly determining what
metabolites are available in the host cell environment and
incorporation of transcriptional regulatory rules into
iRR1083 will allow a more precise analysis of metabolic
selective pressures a pathogen encounters during infec-
tion.
In addition to pathogenicity and virulence analysis, the S.
typhimurium metabolic reconstruction can be a valuable
tool to interpret several 'omics' data types. Although there
is not a direct correlation between gene or protein expres-
sion levels and metabolic fluxes, the genome-scale model
serves as a platform to visualize these large data sets and
interpret them in the context of operational, redundant or
incomplete metabolic pathways. This provides a better
understanding of cellular phenotypes and offers insights
into how system level properties affect survival or sensitiv-
ity of pathogens to factors in the environment provided by
the host cell. For example, the model prediction of fad
genes not being operational during early stages of infec-
tion (optimal growth) and operational during sub-opti-
mal growth can be explained by the fact that fatty acids are
not utilized in the initial stages of infection by S. typhimu-
rium [45]. This observation along with the calculated host
cell reactome from iRR1083 could suggest a switch from
optimal to sub-optimal growth or a change in nutrients
available for Salmonella inside host cell tissue. This switch
is concomitant with a marked decrease in growth during
persistence or chronic infection. Growth rates are presum-
ably higher (optimal) during the initial stage of infection.
The entire reactome of Salmonella  as predicted by the
model provides many hypotheses that need to be further
investigated to identify the implications of metabolic
pathways and functions in pathogenesis. Metabolomic
data have become more readily available and easier toBMC Systems Biology 2009, 3:38 http://www.biomedcentral.com/1752-0509/3/38
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measure. They can be used to apply additional constraints
to the model [58], thus improving model predictions of
cell function and global phenotypes.
The genome-scale model of S. typhimurium we have devel-
oped here also presents us with the opportunity to inter-
rogate several other serovars or species that belong to the
Salmonella genus. For example, panD is the only gene that
is non-functional in Salmonella typhi, and is predicted to
be required for virulence in specific conditions. The pres-
ence of pseudogenes in other serovars can be analyzed in
the context of the genome-scale model to present us with
systemic similarities and differences that may or may not
play a role in the pathogenic potential of all the four spe-
cies. Serovars lacking panD would require panthothenate
from its host. Thus, compounds that affect pantothenate
transport could potentially be used as antibiotics. Such
analyses across different serovars require genome-scale
models and might accelerate the identification of rational
drug targets.
Although many of the reactions in the iRR1083 model for
S. typhimurium are conserved in models for E. coli
MG1655, there are unique metabolic and genetic differ-
ences that affect growth phenotypes in response to differ-
ent environmental or genetic perturbations. The two
organisms are each capable of utilizing unique carbon
sources, which are related to differences in metabolic net-
works (unique transporters or enzymes) or differences in
regulation or kinetics that affect flow through shared reac-
tions common to both organisms (reactions are present to
catabolize carbon sources in both metabolic networks but
one organism does not use them as sole carbon sources).
We also found that there are differences in the number of
isozymes or alternative reactions/pathways that enable
one organism to be more robust against gene deletions in
a glucose minimal media condition. We anticipate that
comparisons of model-predicted essential genes in more
environmental conditions will lead to the identification
of more metabolic differences between the two organ-
isms, as the analysis was only performed for aerobic
growth in glucose minimal media. These metabolic differ-
ences might shed light onto the evolutionary differences
between the two organisms and the nutrients they are or
were exposed to.
The genome-scale metabolic network reconstruction pre-
sented here supports the notion of a robust minimal set of
pathways that Salmonella requires for intracellular survival
during infection [52]. Our model allows in silico simula-
tion of different nutritional requirements and constraints
as they may be present in different host cell types or tis-
sues that are difficult to directly address experimentally.
Our model can generate hypotheses that can be validated
by using mutant strains, high-throughput data, and selec-
tive analysis of pathways. Such an endeavor has the poten-
tial to lead to an improved understanding of how
intracellular pathogens utilize the existing microenviron-
ment of the host. This in turn might lead to the identifica-
tion of conserved metabolic pathways that can be targeted
by novel interfering compounds.
Conclusion
We have presented here extensive datasets within a recon-
struction of a genome-scale metabolic model for S. typh-
imurium  (iRR1083). This model has been validated by
experimental data and by legacy data. It demonstrates an
accuracy of 80% for growth and virulence phenotypes.
Thus the model iRR1083 provides a suitable platform for
computing cellular phenotypes for Salmonella and for fur-
ther integration of high-throughput data.
Biomass composition of Salmonella  was determined
experimentally, which increased the accuracy of our
model building and also showed distinctive difference to
that of E. coli. Constraint-based analysis using the meta-
bolic reconstructions iRR1083 for S. typhimurium and
MG1655 for E. coli identified unique metabolic differ-
ences between these two bacteria.
Expression profiling of selective key metabolic enzymes in
Salmonella  during infection of macrophages identified
operational and non-operational metabolic pathways.
Flux variabity analysis of metabolic pathways identified a
minimal set of reactions required for Salmonella intracel-
lular survival.
This study thus provides another high-resolution recon-
struction of microbial metabolism of an intracellular
pathogen next to that of M. tuberculosis and demonstrates
its suitability for analyzing bacterial metabolic networks
during infection. From further validation and testing of
hypotheses generated from these reconstruction efforts we
expect to arrive at a conserved set of metabolic reactions
that interdigitate with those of the host cell and might
thus provide novel targets for therapeutic intervention.
Methods
Metabolic Network Reconstruction
The reconstruction process for S. typhimurium is outlined
schematically in the Additional file 9. The process fol-
lowed the approach outlined by Edwards and Palsson
(Edwards and Palsson, 2000). The reconstruction was car-
ried out in SimPheny™ (Genomatica, Inc., San Diego,
CA), a platform for development of cellular models. Lists
of genes, proteins and reactions, metabolites and
exchange fluxes that are included in the resulting final
reconstruction can be found in the Additional file 1.
The initial draft reconstruction was built from the anno-
tated genome [25] of Salmonella enterica serovar typhimu-
rium LT2 (S. typhimurium LT2), which is available at TIGR.BMC Systems Biology 2009, 3:38 http://www.biomedcentral.com/1752-0509/3/38
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Genes to proteins to reaction associations (GPR) were
confirmed by comparing homology of S. typhimurium
gene sequences to E. coli gene sequences and biological
information databases such as EXPASY, KEGG, and Bio-
Cyc. These GPR associations connect genetic data to reac-
tions in the metabolic network [26] and allow for
subsequent evaluation of how genetic perturbations affect
metabolic phenotypes.
Biomass Composition and Reaction
A reaction that represents biomass production is included
in the model to account for the drain of precursors and
macromolecular building blocks into biomass. Biomass
was represented as a linear combination of all the macro-
molecular components (lipid, glycogen, lipopolysaccha-
ride, and peptidoglycan) or monomers of
macromolecules (amino acids and nucleotides). Amino
acid and fatty acid composition were experimentally
measured using standard methods described in manual of
bacteriological methods [59]. The relative fatty acid com-
position was used to specify the average fatty acid content
on the phospholipds and diacylglyerol. S. typhimurium
LT2 data from the literature was then used to determine
the amount of lipids (and their phospholipid composi-
tion), lipopolysaccharide, peptidoglycan, and glycogen.
The growth associated ATP maintenance and soluble
metabolite pools were assumed to be the same as reported
for E. coli [9]. Complete details of the cellular composi-
tion and references used for the S. typhimurium biomass
reaction are provided in the Additional file 2. The biomass
reaction thus represents the weighted combination of
components forming the dry weight of the cell and the
amount of ATP hydrolysis, needed for energy during
growth and cellular maintenance.
Flux Balance Analysis
Fluxes through metabolic reactions across the network
can be calculated using flux balance analysis (FBA) [13].
With FBA, the biological system is assumed to be at
steady-state and so all intracellular metabolite concentra-
tions and fluxes are assumed to be constant. The steady-
state assumption makes it possible to compare the simu-
lation results directly to data obtained from cells growing
at a fixed growth rate. FBA is formulated as an optimiza-
tion problem, where constraints are imposed that limit
flux values (steady-state mass balance constraint and
upper and lower bounds for fluxes based on thermody-
namics and substrate uptake constraints). These con-
straints define the range of values that fluxes can take. An
objective function is also used to compare flux distribu-
tions (v) that satisfy all the constraints in order to find
optimal flux distributions. Flux through the biomass pro-
duction reaction has successfully been used as an objec-
tive function for E. coli (along with other objective
functions [60,61], and was used for FBA performed in this
study. Thus, FBA predicts an optimal growth yield and a
flux distribution(s), which correspond to this maximal
growth yield. Alternate optimal solutions exist, and flux
variability analysis [62] was additionally used to identify
the ranges individual fluxes can take while still achieving
the maximal growth yield.
In silico constraints and media composition
Three different environments were used to provide con-
straints for simulations: (i) M9 minimal medium (con-
tains salts, phosphate, sulfate, ammonium minerals) with
an added carbon source; (ii) LB-media (composition was
based on a typical analysis of the yeast extract and tryp-
tone provide by the manufacturer); (iii) host-cell nutrient
environment (representing nutrient conditions inside a
host-cell during Salmonella infection). While the host-cell
nutrient environment was difficult to ascertain, it was
based on an extensive literature review to identify a possi-
ble composition. Details of all simulated media condi-
tions are provided in the Additional file 6. For simulation
of aerobic growth, the following external metabolites
were allowed to freely enter and leave the network: phos-
phate, ammonium, sulfate, water, oxygen, and proton. All
metabolites that were not media components (potential
products) were only allowed to leave the system.
Validation of the model against Biolog data for S. typhimu-
rium  LT2 (available from Biolog website, http://
www.biolog.com/accesstoPMTech.html) was performed
by optimizing biomass production with different carbon
and nitrogen sources. A maximum uptake rate of 5 mmol
per gram of dry weight per hour (mmol/gDW cell/h) was
used for the different carbon and nitrogen sources. Differ-
ent nitrogen sources were simulated with pyruvate as a
carbon source and different carbon sources were simu-
lated with ammonium as a nitrogen source.
Gene Essentiality
Genetic changes, such as gene deletions and mutations,
can be simulated by adding additional constraints to indi-
vidual fluxes [38]. For example, deletion of an enzyme
subunit would force flux values through associated reac-
tions to be zero, unless other isozymes are present. The
essentiality of a given gene was determined by calculating
the maximal growth rate using FBA when fluxes through
associated reactions were constrained to be zero. This type
of analysis identifies lethal gene deletions (where maxi-
mum growth rate is zero) and non-lethal gene deletions
(where maximum growth rate is greater than zero). Gene
essentiality is dependent on media composition, and all
three growth environments (M9 minimal media with glu-BMC Systems Biology 2009, 3:38 http://www.biomedcentral.com/1752-0509/3/38
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cose, LB media, and host-cell nutrient environment) were
analyzed separately.
Growth and Infection Experiments
All growth experiments were carried out using the strain S.
enterica serovar typhimurium LT2. Aerobic batch cultivation
was done in an incubator shaker at 37°C and 100 rpm.
Minimal M9 medium was supplemented with 6 different
carbon sources (glucose, fructose, glycerol, arabinose,
ribose and xylose). The cell culture optical density (OD)
was monitored at regular intervals using a Beckman DU
spectrophotometer at 600 nm. The OD was converted
into g dry weight using a previously determined biomass
calibration standard curve using the same spectropho-
tometer (gDW = 0.7396·OD600). Samples were also with-
drawn every 2 hours, filtered and the supernatants were
frozen and stored at -80°C for HPLC analysis to analyze
substrate utilization and product formation profiles.
HPLC Analysis
Organic acid and sugar analysis was done using an ion
exchange Aminex 87H+ column (Biorad). A 5 mM Sulfuric
acid mobile phase at a flow rate of 0.5 ml/min at 65°C
was used for separation. Both UV and RI (refractive index)
detector were employed. Small molecules were quantified
using a previously determined calibration curve.
Quantitative Gene expression using GeXP™
Infection of the macrophage like cell line (RAW246.7)
was carried out as described [63]. RNA was purified from
harvested bacterial cells using the protocol from RNeasy
Kit (QIAGEN) and quantitated using UV detection at 260
nm and 280 nm. The GenomeLab™ GeXP Genetic Analy-
sis System (Beckman) was used for quantitative gene
expression analysis of the selected metabolic transcrip-
tome of S. typhimurum. GeXP employs eXpress Profiling
(XP-PCR), a patented technology for multiplex gene
expression profiling analysis by which up to 30 genes can
be easily multiplexed in the same reaction. We used a pro-
tocol that comes with GeXP Reagent kits that involved five
basic steps: 1) Primer design; 2) cDNAsynthesis; 3) PCR;
4) Separation on the GenomeLab GeXP Genetic Analysis
System; 5) Fragment Analysis and Expression Profiling.
The data was then analyzed using the GeXP analysis pro-
prietary software (Beckman, Inc.), Excel (Microsoft, Inc.)
and Matlab (Mathworks, Inc.). Primers were designed
using proprietary software provided by Beckman (see
Additional file 10).
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